profit-sharing bonus (up to 5%) + individual bonus (up to 5%) Mobility : Occasional in Western Europe (France
profit-sharing bonus (up to 5%) + individual bonus (up to 5%) Mobility : Occasional in Western Europe (France
profit-sharing bonus (up to 5%) + individual bonus (up to 5%) Mobility : Occasional in Western Europe (France
profit-sharing bonus (up to 5%) + individual bonus (up to 5%) Mobility : Occasional in Western Europe (France
profit-sharing bonus (up to 5%) + individual bonus (up to 5%) Mobility : Occasional in Western Europe (France
regulated industry (such as Medical Device).This role is a remote role based in Portugal, Spain, Italy, France
regulated industry (such as Medical Device).This role is a remote role based in Portugal, Spain, Italy, France
hybrid working in Zurich, Warsaw, Tampere, and London.Excellent support for remote work across the UK, France
of plant staff; build strong business relationships and networks Position Details:Remote role from France
a home based role in Germany (ideally in the North), or in the borders of The Netherlands, Belgium, France
Funding category: Contrat doctoral 3 years - full time PHD title: Physics PHD Country: France Requirements
Funding category: Contrat doctoral 3 years - full time PHD title: Physics PHD Country: France Requirements
Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France,
Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France,
Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France,
to the beautiful city of Strasbourg (with a world-famous Christmas market) in the Alsace region of France
2 and/or Agile methodologies is considered an asset; EXTRA INFORMATION Work location: Strasbourg, France
This position can be open in Liege (Belgium) / Florange (France) / Luxembourg (Luxembourg) What does
Division: Global Technology Department: Digital Manufacturing - Deployment Location(s): FR - France
Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France,
CD affects a substantial portion of the population in France and Europe, with considerable impacts on
